Due to recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the homepage of the official account to get the latest trends and expert insights in the digital healthcare industry第一时间!
01 Global Digital Health Investment and Financing OverviewMental Health Care Provider Talkiatry Secures $130 Million in Series C FundingOn June 18, mental health care provider Talkiatry secured $130 million in Series C funding. This round of equity financing was led by Andreessen Horowitz, with debt financing provided by Banc of California. The Series C funding will drive Talkiatry to further expand its value-based care model in behavioral health, reduce overall health care costs, improve health outcomes, and save actual expenses for patients, health plans, health systems, or institutional partners.AI Drug Discovery Platform Iambic Therapeutics Secures $50 Million in Series B FinancingOn June 18, AI drug discovery platform Iambic Therapeutics secured a $50 million Series B financing round. The round was led by new investors Mubadala Capital and Exor Ventures. Proceeds from the latest funding will be used to further advance Iambic's clinical and preclinical programs, including IAM1363, which aims to expand the therapeutic window and address treatment resistance in solid tumors such as breast cancer.Minimally Invasive Surgical Robot Developer Ronovo Completes Over 300 Million RMB Series B FinancingOn June 14, Ronovo Surgical, a developer of minimally invasive surgical robots, completed a Series B financing round of over 300 million RMB. The round was co-led by Wuxi Guolian (under which are Guolian Tongbao, Xizhou International, and Yangzhou Economic Development New Industry Fund) and INCE Capital, with participation from King Star Med LP and existing shareholder LongRiver Jiangyuan Investment. The proceeds will accelerate the commercialization of the modular HaiShan One surgical robot and advance the company’s international strategy.Nomad Health, a Doctor Job Matching Platform, Raises $22 Million in FinancingOn June 17, Nomad Health, a doctor job-matching platform, secured $22 million in funding led by HealthQuest Capital. This round of financing will enable Nomad to expand its product portfolio, improve clinician staffing, and meet the ongoing demand for its staffing assistance technology, which allows clinicians to be deployed more quickly to the places where they are most needed.Oral Data Service Platform Health-Miumiu Completes Nearly 100 Million Yuan in B-Round FinancingOn June 19, Health-Miumiu(Hangzhou) Medicine Co., Ltd., an oral data service platform, completed a nearly RMB 100 million Series B financing round. This round was jointly invested by Blue Bay Capital, Kangdelai, and Yika Capital, with existing shareholder KIP once again increasing its investment. The funds will mainly be used to strengthen the information technology upgrade and customized service transformation of the comprehensive oral platform, becoming a trusted partner for dentists worldwide.Chronic Disease Management Service Provider Better Health Secures $14 Million in Strategic FinancingOn June 13, Better Health, a disease management service provider, secured $14 million in strategic funding from investors including Healthworx, UHealth, and Mosaic General Partnership. The funds will be used to offer more comprehensive solutions for payers and providers while expanding into new categories to better serve members with chronic conditions.Internet Community Healthcare Platform Marigold Health Raises $11 Million in Series A FundingResourcesOn June 18, internet-based community healthcare platform Marigold Health secured $11 million in Series A funding. The round was led by Rock Health and Innospark Ventures. Marigold Health’s peer support program combines expert one-on-one coaching, 24/7 access through an app, and integrates natural language processing to flag health needs expressed in chats, triggering additional support when necessary.Digital Therapeutics Developer for Neuromuscular Diseases JOGO Health Raises $5.5 MillionOn June 18, JOGO Health, a developer of digital therapeutics for neuromuscular diseases, secured $5.5 million in funding led by Hourglass Ventures, with participation from Mayo Clinic Ventures. The funds raised will support JOGO's commercial launch, positioning JOGO to potentially become a first-line treatment for chronic pain and other neuromuscular disorders.Pharmacy Software Developer RedSail Receives Strategic InvestmentOn June 13, pharmacy software developer RedSail received strategic funding from Leonard Green & Partners and Francisco Partners. This investment will advance RedSail’s business by establishing the most clinically advanced and financially sustainable pharmacy network, enhancing the role of pharmacies and community health. It currently provides financial and clinical benefits support to over 12,000 pharmacies.AI Medical Imaging Product Developer Promaxo Secures New Round of FinancingOn June 18, AI medical imaging product developer Promaxo secured a new round of financing from Zynext Ventures USA LLC. ProMaxo combines barrier-free MRI technology with robotics for guided interventions, which has the potential to significantly improve patient outcomes and expand access to critical care image-guided interventions for everyone.Ophthalmic Surgical Robot Developer Xianwei Medical Secures New Round of FinancingOn June 20, ophthalmic surgical robot developer Xianwei Medical completed a new round of financing, led by Wuhan Biotechnology Research Institute's Baiying Huicai Fund and Zhongxi Fund. The funds will be used for team building and the development of ophthalmic surgical robots. The company focuses on the field of ophthalmic surgical robots, has iterated through three generations of surgical systems, and has planned three product pipelines, aiming to obtain Class III medical device certification within the next two to three years.Generative AI Protein Design Platform BioGeometric Completes Pre-A Round FinancingOn June 19, GeomBio, a generative AI protein design platform, completed its Pre-A round of financing led by TsingTech Ventures, with participation from Zhipu AI and Shengjing Jicheng. Existing shareholder Gao Rong Ventures continued to increase its investment. The funds from this round will mainly be used to accelerate the implementation of large-scale generative AI models in the biomanufacturing field and to advance the development of proprietary products.Precision Medicine Health Management Service Provider Zhongke Weisheng Receives New Round of Strategic FinancingOn June 17, precision medicine health management service provider Zhongke Weisheng received a new round of strategic financing from China Precision Medicine Research Center. The completion of this strategic investment marks that Zhongke Weisheng and China Precision Medicine will achieve deep integration of industrial resources, jointly promote the efficient transformation and wide application of cutting-edge technologies, and lead the precision medicine field into a new stage of development.02 Digital Health Industry DynamicsAscentage Pharma Enters into Exclusive Option Agreement with TakedaOn June 14, Ascentage Pharma announced that it had signed an exclusive option agreement with Takeda for the company’s third-generation BCR-ABL tyrosine kinase inhibitor (TKI) Olverembatinib (HQP1351), which has best-in-class potential. According to the terms of the option agreement, Ascentage Pharma will receive a $100 million option payment upon signing the agreement and is eligible to receive up to approximately $1.2 billion in option exercise fees as well as additional potential milestone payments.Mingji Biotech Reaches $1.7 Billion Licensing Agreement with AbbVieOn June 13, MabGen Biotech and AbbVie jointly announced the signing of a licensing agreement for the development of FG-M701. FG-M701 is a next-generation TL1A antibody for the treatment of inflammatory bowel disease (IBD), currently in the preclinical development stage. Under the terms of the agreement, AbbVie will obtain exclusive global rights to develop, manufacture, and commercialize FG-M701. MabGen Biotech will receive $150 million as an upfront payment and near-term milestone payments, and is eligible to receive additional milestone payments of up to $1.56 billion related to clinical development, regulatory registration, and commercialization, as well as tiered royalties of up to a low double-digit percentage of net sales.Calidi Biotherapeutics Partners with SIGA TechnologiesOn June 10, Calidi Biotherapeutics, a developer of next-generation targeted oncolytic virus therapies, announced a collaboration agreement with SIGA Technologies to support the development of Calidi's systemic and targeted RTNova (CLD-400) virus therapy platform, which has the potential to offer a universal treatment for all tumor types.03 Overview of Global Digital Health M&ABoston Scientific Acquires Silk Road Medical for $1.16 BillionOn June 18, Boston Scientific announced that it would acquire Silk Road Medical, the company pioneering Transcarotid Artery Revascularization (TCAR), for $27.50 per share, at a total price of approximately $1.16 billion (about 8.417 billion RMB). The two parties have reached a definitive agreement, and the acquisition is expected to be completed in the second half of this year. After the transaction is completed, Silk Road Medical will become a wholly-owned subsidiary of Boston Scientific. Once the acquisition is completed, it is expected to bring Boston Scientific net revenue of $194 million to $198 million this year.Haier Group Completes Acquisition of Shanghai RAAS for 12.5 BillionOn June 18, Haier Group announced the completion of its strategic investment in Shanghai RAAS. Through Haiyingkang, Haier Group acquired a 20% stake in Shanghai RAAS held by Grifols, one of the world's top three plasma product giants, for a total price of 12.5 billion yuan. After the completion of the entire transaction, Haiyingkang will hold a total of 26.58% of the voting rights and become the actual controlling shareholder of the company.Artery Network/Arterial Orange Industry Think Tank/China Renaissance/BGI Co-Win/Rock Health/Mobile Health News/Fierce Health, etc.
Compiled by: Zhang Qiankun
